期刊
RESTORATIVE NEUROLOGY AND NEUROSCIENCE
卷 28, 期 4, 页码 589-603出版社
IOS PRESS
DOI: 10.3233/RNN-2010-0543
关键词
Human; embryonic; cells; progenitors; differentiation; ectoderm; endoderm; mesoderm; karyotype; feeder-free; synthetic scaffolds; hydrogels; hyaluronic acid; hepatocyte; embryoid bodies; mesenchymal; osteocytes; chondrocytes; stromal; hematopoietic; cardiomyocytes; endothelial; epithelial; neural; neurons; motor neurons; dopaminergic neurons; oligodendrocytes; myelination; degenerative disorders; transplantation
资金
- NIDA, NIH, DHHS
- NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000472] Funding Source: NIH RePORTER
The greatest therapeutic promise of human embryonic stem cells (hESC) is to generate specialized cells to replace damaged tissue in patients suffering from various degenerative diseases. However, the signaling mechanisms involved in lineage restriction of ESC to adopt various cellular phenotypes are still under investigation. Furthermore, for progression of hESC-based therapies towards clinical applications, appropriate culture conditions must be developed to generate genetically stable homogenous populations of cells, to hinder possible adverse effects following transplantation. Other critical challenges that must be addressed for successful cell implantation include problems related to survival and functional efficacy of the grafted cells. This review initially describes the derivation of hESC and focuses on recent advances in generation, characterization, and maintenance of these cells. We also give an overview of original and emerging differentiation strategies used to convert hESC to different cell types. Finally, we will discuss transplantation studies of hESC-derived cells with respect to safety and functional recovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据